Bausch Health Cos Pre-Paid Expenses 2010-2024 | BHC

Bausch Health Cos pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
Bausch Health Cos Annual Pre-Paid Expenses
(Millions of US $)
2023 $1,092
2022 $776
2021 $720
2020 $855
2019 $779
2018 $689
2017 $771
2016 $696
2015 $963
2014 $651
2013 $343
2012 $130
2011 $42
2010 $26
2009 $15
Bausch Health Cos Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $852
2024-06-30 $874
2024-03-31 $957
2023-12-31 $1,092
2023-09-30 $1,048
2023-06-30 $890
2023-03-31 $796
2022-12-31 $776
2022-09-30 $718
2022-06-30 $820
2022-03-31 $765
2021-12-31 $720
2021-09-30 $632
2021-06-30 $899
2021-03-31 $924
2020-12-31 $855
2020-09-30 $726
2020-06-30 $776
2020-03-31 $745
2019-12-31 $779
2019-09-30 $631
2019-06-30 $698
2019-03-31 $693
2018-12-31 $689
2018-09-30 $757
2018-06-30 $835
2018-03-31 $833
2017-12-31 $771
2017-09-30 $736
2017-06-30 $710
2017-03-31 $675
2016-12-31 $696
2016-09-30 $1,007
2016-06-30 $897
2016-03-31 $910
2015-12-31 $963
2015-09-30 $953
2015-06-30 $1,075
2015-03-31 $661
2014-12-31 $651
2014-09-30 $466
2014-06-30 $453
2014-03-31 $370
2013-12-31 $343
2013-09-30 $257
2013-06-30 $115
2013-03-31 $137
2012-12-31 $130
2012-09-30 $72
2012-06-30 $56
2012-03-31 $52
2011-12-31 $42
2011-09-30 $33
2011-06-30 $25
2011-03-31 $34
2010-12-31 $26
2010-09-30 $41
2010-06-30 $10
2010-03-31 $13
2009-12-31 $15
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00